Minimal Important Difference and Responsiveness to Change of the SF-36 in Patients With Psoriatic Arthritis Receiving Tumor Necrosis Factor- Blockers

Journal of Rheumatology - Canada
doi 10.3899/jrheum.101256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Weight Loss and Achievement of Minimal Disease Activity in Patients With Psoriatic Arthritis Starting Treatment With Tumour Necrosis Factor Α Blockers

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2010English

Cost of Tumor Necrosis Factor Blockers Per Patient With Rheumatoid Arthritis in a Multistate Medicaid Population

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2014English

Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

Maintenance of Cytomegalovirus-Specific CD4pos T-Cell Response in Rheumatoid Arthritis Patients Receiving Anti-Tumor Necrosis Factor Treatments

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Effect of the Biological Drug Etanercept on Tumor Necrosis Factor-Α Levels in Psoriatic Patients

Iraqi Journal of Science
GeneticsMolecular BiologyGeologyBiochemistryComputer ScienceBiotechnologyChemistry
2018English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy